source
- Definium's LSD pill shows significant anxiety reduction in Phase 3 trialDefinium Therapeutics announced results of a Phase 3 trial testing its LSD‑based pill DT120 in patients with generalized anxiety disorder. The study enrolled 214 participants who received a single…
- WHO and DRC move to fast-track Phase 3 Ebola vaccine trial, starting with Merck’s ErveboThe World Health Organization and authorities in the Democratic Republic of the Congo are negotiating to speed up the launch of a multi‑armed Phase 3 trial of Ebola vaccines. The effort targets th…